|
蛋白酶活化受体4 的研究进展 |
|
; 综上所述,虽然人们对PAR4的分布、活化、生物学效应等有了一定的了解,但还需对PAR4 介导的发病机制进行更深入的探索。目前研究认为凝血酶、胰蛋白酶、类胰蛋白酶等能够激活PAR4 , 参与某些凝血异常疾病,呼吸道或非呼吸道疾病的发生、发展过程,深入研究PAR4与这些疾病的病理过程的关系,可以使人们对 PAR4的功能有更加深入的认识。
【参考文献】 [1] XU W F,ANDERSEN H, WHITMORE T E, et al. Cloning and characterization of human protease-activated receptor 4[J].Proc-Natl Acad Sci USA, 1998 , 95(12): 6642-6646.
[2] HOLLENBERG M D,SAIFEDDINE M,SANDHU, et al. Proteinase-activated receptor-4: evaluation of tethered ligand-derived peptides as probes for receptor function and as inflammatory agonists in vivo [J]. Br J Pharmacol, 2004 , 143(4): 443-454.
[3] SHAPIRO M J, WEISS E J, FARUQI T R, et al. Protease-activated receptors 1 and 4 are shut off with distinct kinetics after activation by thrombin[J]. J Biol Chem,2000, 275(33): 25216-25221.
[4] MOMOTA F, HIRANO K,HIRANO M, et al. Involvement of Gi/o in the PAR-4-induced NO production in endothelial cells[J]. Biochem Biophys Res Commun, 2006 ,342(2): 365-371.
[5] COVIC L, GRESSER A L, KULIOPULOS A ,et al. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets[J].Biochemistry, 2000 ,39(18): 5458-5467.
[6] BAEK OS,KANG OH,CHOI YA 上一页 [1] [2] [3] [4] [5] [6] [7] 下一页 上一个医学论文: 继发于系统性红斑狼疮的抗磷脂综合征肾病1例 下一个医学论文: 以癫痫为首发症状的抗磷脂抗体综合征1例报道
|
|
|
|
|
|
|